| 000 | 01619 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250517171159.0 | ||
| 264 | 0 | _c20171027 | |
| 008 | 201710s 0 0 eng d | ||
| 022 | _a1432-0584 | ||
| 024 | 7 |
_a10.1007/s00277-017-3104-9 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aOh, Sang-Bo | |
| 245 | 0 | 0 |
_aTherapeutic decision-making in elderly patients with acute myeloid leukemia: conventional intensive chemotherapy versus hypomethylating agent therapy. _h[electronic resource] |
| 260 |
_bAnnals of hematology _cNov 2017 |
||
| 300 |
_a1801-1809 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Multicenter Study | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntimetabolites, Antineoplastic _xadministration & dosage |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadministration & dosage |
| 650 | 0 | 4 |
_aAzacitidine _xadministration & dosage |
| 650 | 0 | 4 |
_aClinical Decision-Making _xmethods |
| 650 | 0 | 4 |
_aDNA Methylation _xdrug effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeukemia, Myeloid, Acute _xdiagnosis |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aSurvival Rate _xtrends |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aPark, Sung-Woo | |
| 700 | 1 | _aChung, Joo-Seop | |
| 700 | 1 | _aLee, Won-Sik | |
| 700 | 1 | _aLee, Ho-Seop | |
| 700 | 1 | _aCho, Su-Hee | |
| 700 | 1 | _aChoi, Yoon-Suk | |
| 700 | 1 | _aLim, Sung-Nam | |
| 700 | 1 | _aShin, Ho-Jin | |
| 773 | 0 |
_tAnnals of hematology _gvol. 96 _gno. 11 _gp. 1801-1809 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00277-017-3104-9 _zAvailable from publisher's website |
| 999 |
_c27485751 _d27485751 |
||